Tilray Brands reported fourth quarter fiscal 2026 revenue of $281.7 million, a 25% increase year-over-year and well ahead of the $249.6 million consensus estimate. The company posted an adjusted EPS of $0.05, strongly beating expectations for a $0.02 loss. For the full fiscal year, revenue grew 11% to $915.5 million with adjusted EPS of $0.11.
Key Highlights
- The beverage segment showed significant acceleration, with fourth-quarter revenue growing to $105.6 million from $65.6 million in the prior-year period, a 61% increase.
- International medical cannabis remained a key growth engine, with revenue for the full fiscal year increasing by 34%.
- Tilray issued fiscal 2027 adjusted EBITDA guidance in the range of $68 million to $75 million, surpassing prior analyst expectations of approximately $67 million.